Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
Blood
|
February 27, 2026
CSNK1E Sustains Stem-like Drug Persistence in Diffuse Large B-cell Lymphoma
Xiang Li, Mengke Liu, Qing Shi, et al.
Signal Transduction and Targeted Therapy
|
March 6, 2024
Anti-metabolic agent pegaspargase plus PD-1 antibody sintilimab for first-line treatment in advanced natural killer T cell lymphoma
Jie Xiong, Shu Cheng, Xiao Gao, et al.
Genome Medicine
|
October 24, 2025
Clinical characteristics and molecular heterogeneity in Follicular lymphoma with extranodal involvement
Rui-Chi Li, Wei Tang, Hui-Lai Zhang, et al.
Clinical and Translational Medicine
|
May 30, 2024
Molecular heterogeneity of BCL2/MYC double expressor lymphoma underlies sensitivity to histone deacetylase inhibitor
Zi-Yang Shi, Ying Fang, Peng-Peng Xu, et al.
Cancer Cell
|
September 29, 2023
Genetic subtype-guided immunochemotherapy in diffuse large B cell lymphoma: The randomized GUIDANCE-01 trial
Mu-Chen Zhang, Shuang Tian, Di Fu, et al.
Cell Reports. Medicine
|
March 20, 2025
Practical microenvironment classification in diffuse large B cell lymphoma using digital pathology
Yu-Qing Wang, Shuo Wang, Hong-Mei Yi, et al.
Clinical and Translational Medicine
|
April 23, 2025
Response-adapted zanubrutinib and tislelizumab as a potential strategy to enhance CD19 CAR T-cell therapy in relapsed/refractory large B-cell lymphoma: A retrospective observational study
Rong Shen, Wei-Guo Cao, Li Wang, et al.
Cell Reports. Medicine
|
November 19, 2025
A prognostic index integrating deep learning baseline PET/CT biomarkers and multi-omics profiling in diffuse large B cell lymphoma
Yue Wang, Xue Wang, Xin-Yun Huang, et al.
Science Bulletin
|
October 5, 2023
GPCR signaling contributes to immune characteristics of microenvironment and process of EBV-induced lymphomagenesis
Jie Xiong, Yu-Ting Dai, Wen-Fang Wang, et al.
Ebiomedicine
|
April 11, 2025
Molecular heterogeneity of CD30<sup>+</sup> peripheral T-cell lymphoma with prognostic significance and therapeutic implications: a retrospective multi-centre study
Yu-Jia Huo, Shu Cheng, Hong-Mei Yi, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
Blood
|
February 27, 2026
CSNK1E Sustains Stem-like Drug Persistence in Diffuse Large B-cell Lymphoma
Xiang Li, Mengke Liu, Qing Shi, et al.
Signal Transduction and Targeted Therapy
|
March 6, 2024
Anti-metabolic agent pegaspargase plus PD-1 antibody sintilimab for first-line treatment in advanced natural killer T cell lymphoma
Jie Xiong, Shu Cheng, Xiao Gao, et al.
Genome Medicine
|
October 24, 2025
Clinical characteristics and molecular heterogeneity in Follicular lymphoma with extranodal involvement
Rui-Chi Li, Wei Tang, Hui-Lai Zhang, et al.
Clinical and Translational Medicine
|
May 30, 2024
Molecular heterogeneity of BCL2/MYC double expressor lymphoma underlies sensitivity to histone deacetylase inhibitor
Zi-Yang Shi, Ying Fang, Peng-Peng Xu, et al.
Cancer Cell
|
September 29, 2023
Genetic subtype-guided immunochemotherapy in diffuse large B cell lymphoma: The randomized GUIDANCE-01 trial
Mu-Chen Zhang, Shuang Tian, Di Fu, et al.
Cell Reports. Medicine
|
March 20, 2025
Practical microenvironment classification in diffuse large B cell lymphoma using digital pathology
Yu-Qing Wang, Shuo Wang, Hong-Mei Yi, et al.
Clinical and Translational Medicine
|
April 23, 2025
Response-adapted zanubrutinib and tislelizumab as a potential strategy to enhance CD19 CAR T-cell therapy in relapsed/refractory large B-cell lymphoma: A retrospective observational study
Rong Shen, Wei-Guo Cao, Li Wang, et al.
Cell Reports. Medicine
|
November 19, 2025
A prognostic index integrating deep learning baseline PET/CT biomarkers and multi-omics profiling in diffuse large B cell lymphoma
Yue Wang, Xue Wang, Xin-Yun Huang, et al.
Science Bulletin
|
October 5, 2023
GPCR signaling contributes to immune characteristics of microenvironment and process of EBV-induced lymphomagenesis
Jie Xiong, Yu-Ting Dai, Wen-Fang Wang, et al.
Ebiomedicine
|
April 11, 2025
Molecular heterogeneity of CD30<sup>+</sup> peripheral T-cell lymphoma with prognostic significance and therapeutic implications: a retrospective multi-centre study
Yu-Jia Huo, Shu Cheng, Hong-Mei Yi, et al.
Page
of 5